Skip to main content


Fig. 6 | BMC Cancer

Fig. 6

From: HOX transcription factors are potential targets and markers in malignant mesothelioma

Fig. 6

HXR9 blocks the growth of mesothelioma tumors in vivo. a The growth of MSTO-211H tumors in xenograft mice injected IP every 4 days with PBS or 25 mg/Kg HXR9, for a total of five times. P values were calculated using a Student’s t-test for each time point, “*” indicates statistical significance (p = 0.008, p = 0.037, and p = 0.041 for days 30, 34, and 37, respectively. b HOXB4 expression in the excised tumors from PBS-treated mice, as determined by QRT-PCR. There was a linear relationship between tumor size and HOXB4 expression (r2 = 0.8278; p = 0.0321)

Back to article page